ESR1 and breast carcinoma: However, in the 1980s, it underwent a transformative journey when clinical trials revealed its efficacy in treating estrogen receptor (ER)-positive breast cancer [1]. Tamoxifen is now a cornerstone of adjuvant hormonal therapy for women with breast cancer.